Dinesh Naidoo to Humans
This is a "connection" page, showing publications Dinesh Naidoo has written about Humans.
Connection Strength
0,187
-
Traumatic brain injury: the South African landscape. S Afr Med J. 2013 Aug 02; 103(9):613-4.
Score: 0,033
-
Self-assembling peptides: implications for patenting in drug delivery and tissue engineering. Recent Pat Drug Deliv Formul. 2011 Jan; 5(1):24-51.
Score: 0,028
-
Levodopa delivery systems: advancements in delivery of the gold standard. Expert Opin Drug Deliv. 2010 Feb; 7(2):203-24.
Score: 0,026
-
Nanotechnological applications for the treatment of neurodegenerative disorders. Prog Neurobiol. 2009 Aug; 88(4):272-85.
Score: 0,025
-
Implantable and transdermal polymeric drug delivery technologies for the treatment of central nervous system disorders. Pharm Dev Technol. 2017 Jun; 22(4):476-486.
Score: 0,010
-
Development and in vivo evaluation of an implantable nano-enabled multipolymeric scaffold for the management of AIDS dementia complex (ADC). Int J Pharm. 2015 Dec 30; 496(2):863-77.
Score: 0,010
-
A review of the potential role of nano-enabled drug delivery technologies in amyotrophic lateral sclerosis: lessons learned from other neurodegenerative disorders. J Pharm Sci. 2015 Apr; 104(4):1213-29.
Score: 0,009
-
Multifunctional therapeutic delivery strategies for effective neuro-regeneration following traumatic spinal cord injury. Curr Pharm Des. 2015; 21(12):1517-28.
Score: 0,009
-
Nanoparticulate strategies for the five R's of traumatic spinal cord injury intervention: restriction, repair, regeneration, restoration and reorganization. Nanomedicine (Lond). 2014 Feb; 9(2):331-48.
Score: 0,009
-
A review of integrating electroactive polymers as responsive systems for specialized drug delivery applications. J Biomed Mater Res A. 2014 Jun; 102(6):2039-54.
Score: 0,008
-
Fabrication, modeling and characterization of multi-crosslinked methacrylate copolymeric nanoparticles for oral drug delivery. Int J Mol Sci. 2011; 12(9):6194-225.
Score: 0,007
-
In silico theoretical molecular modeling for Alzheimer's disease: the nicotine-curcumin paradigm in neuroprotection and neurotherapy. Int J Mol Sci. 2011 Jan 19; 12(1):694-724.
Score: 0,007
-
Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders. Int J Mol Sci. 2009 Jun 03; 10(6):2510-57.
Score: 0,006